Kevin Andrew Robbins bought MTEX once, on May 19, 2026
Director at Mannatech, Incorporated
SEC CIK 0001691941 · Filings on SEC.gov ↗
Kevin Andrew Robbins's record
3 months after each buy, from the first price a copier could get.
1 buy has 3 months of prices so far. A record shows here at 3.
Every filing
6 filings since Aug 2021, newest first
About Kevin Andrew Robbins
Kevin Andrew Robbins is a corporate director in the health and nutrition products sector and a member of the board of directors of Mannatech, Incorporated (NASDAQ: MTEX), a global wellness and nutritional supplement company.( The son of Mannatech co‑founder Ray Robbins, he was appointed to Mannatech’s board in December 2016 as a Class I director, reflecting his long association with the company and the industry.( His experience includes an extended tenure with Mannatech in various capacities, contributing to the company’s growth in health and nutrition markets.(
As of May 19, 2026, Robbins serves as a director and corporate insider of Mannatech and has been an active investor in the company’s stock.( On that date, he purchased 7,100 shares of Mannatech common stock in an open‑market transaction at a weighted average price of $4.17 per share, for a total of approximately $29,607, increasing his direct holdings to 33,333 shares.( Public disclosures estimate his net worth, based on these holdings, at a minimum of about $48,603 as of May 18, 2026.( Specific details of his formal education and earlier career roles beyond Mannatech are not publicly disclosed in the cited sources.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.